164 related articles for article (PubMed ID: 12218163)
21. M-Vax: an autologous, hapten-modified vaccine for human cancer.
Berd D
Expert Rev Vaccines; 2004 Oct; 3(5):521-7. PubMed ID: 15485331
[TBL] [Abstract][Full Text] [Related]
22. Primary structure and complementarity-determining region (CDR) 3 spectratyping of rainbow trout TCRbeta transcripts identify ten Vbeta families with Vbeta6 displaying unusual CDR2 and differently spliced forms.
Boudinot P; Boubekeur S; Benmansour A
J Immunol; 2002 Dec; 169(11):6244-52. PubMed ID: 12444130
[TBL] [Abstract][Full Text] [Related]
23. Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine.
Sato T
Cancer Immunol Immunother; 1996 Nov; 43(3):174-9. PubMed ID: 9001571
[TBL] [Abstract][Full Text] [Related]
24. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire.
Lim A; Trautmann L; Peyrat MA; Couedel C; Davodeau F; Romagné F; Kourilsky P; Bonneville M
J Immunol; 2000 Aug; 165(4):2001-11. PubMed ID: 10925283
[TBL] [Abstract][Full Text] [Related]
25. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
Sensi M; Traversari C; Radrizzani M; Salvi S; Maccalli C; Mortarini R; Rivoltini L; Farina C; Nicolini G; Wölfel T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5674-8. PubMed ID: 7777568
[TBL] [Abstract][Full Text] [Related]
27. Autologous, hapten-modified vaccine as a treatment for human cancers.
Berd D; Kairys J; Dunton C; Mastrangelo MJ; Sato T; Maguire HC
Semin Oncol; 1998 Dec; 25(6):646-53. PubMed ID: 9865679
[TBL] [Abstract][Full Text] [Related]
28. T-cell receptor V beta gene expression differs in tumor-infiltrating lymphocytes within primary and metastatic melanoma.
Nitta T; Bell R; Okumura K; Sato K; Steinman L
Cancer Res; 1991 Oct; 51(20):5565-9. PubMed ID: 1655255
[TBL] [Abstract][Full Text] [Related]
29. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
[TBL] [Abstract][Full Text] [Related]
30. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.
Schøller J; thor Straten P; Birck A; Siim E; Dahlström K; Drzewiecki KT; Zeuthen J
Cancer Immunol Immunother; 1994 Oct; 39(4):239-48. PubMed ID: 7954526
[TBL] [Abstract][Full Text] [Related]
31. Clonality of tumor-infiltrating lymphocytes in human urinary bladder carcinoma.
Velotti F; Chopin D; Gil-Diez S; Maille P; Abbou CC; Kourilsky P; Even J
J Immunother; 1997 Nov; 20(6):470-8. PubMed ID: 9409453
[TBL] [Abstract][Full Text] [Related]
32. Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients.
Ochsenreither S; Fusi A; Geikowski A; Stather D; Busse A; Stroux A; Letsch A; Keilholz U
Cancer Immunol Immunother; 2012 Mar; 61(3):313-22. PubMed ID: 21898091
[TBL] [Abstract][Full Text] [Related]
33. Differential transcriptional regulation of individual TCR V beta segments before gene rearrangement.
Chen F; Rowen L; Hood L; Rothenberg EV
J Immunol; 2001 Feb; 166(3):1771-80. PubMed ID: 11160223
[TBL] [Abstract][Full Text] [Related]
34. Islet-associated T-cell receptor-β CDR sequence repertoire in prediabetic NOD mice reveals antigen-driven T-cell expansion and shared usage of VβJβ TCR chains.
Toivonen R; Arstila TP; Hänninen A
Mol Immunol; 2015 Mar; 64(1):127-35. PubMed ID: 25480393
[TBL] [Abstract][Full Text] [Related]
35. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.
Ebato M; Nitta T; Yagita H; Sato K; Okumura K
Eur J Immunol; 1994 Dec; 24(12):2987-92. PubMed ID: 7805726
[TBL] [Abstract][Full Text] [Related]
36. Conserved T-cell receptor beta chain CDR3 sequences in IgA nephropathy biopsies.
Wu H; Zhang GY; Clarkson AR; Knight JF
Kidney Int; 1999 Jan; 55(1):109-19. PubMed ID: 9893119
[TBL] [Abstract][Full Text] [Related]
37. Differences in TCR-Vβ repertoire and effector phenotype between tumor infiltrating lymphocytes and peripheral blood lymphocytes increase with age.
Shao H; Ou Y; Wang T; Shen H; Wu F; Zhang W; Tao C; Yuan Y; Bo H; Wang H; Huang S
PLoS One; 2014; 9(7):e102327. PubMed ID: 25019226
[TBL] [Abstract][Full Text] [Related]
38. Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts.
Gagne K; Brouard S; Giral M; Sebille F; Moreau A; Guillet M; Bignon JD; Imbert BM; Cuturi MC; Soulillou JP
J Immunol; 2000 Feb; 164(3):1553-63. PubMed ID: 10640774
[TBL] [Abstract][Full Text] [Related]
39. Dinitrophenyl-modified autologous melanoma vaccine induces a T cell response to hapten-modified, melanoma peptides.
Sato T; Bullock TN; Eisenlohr LC; Mastrangelo MJ; Berd D
Clin Immunol Immunopathol; 1997 Dec; 85(3):265-72. PubMed ID: 9400626
[TBL] [Abstract][Full Text] [Related]
40. Donor-specific blood transfusion-induced tolerance in adult rats with a dominant TCR-Vbeta rearrangement in heart allografts.
Douillard P; Pannetier C; Josien R; Menoret S; Kourilsky P; Soulillou JP; Cuturi MC
J Immunol; 1996 Aug; 157(3):1250-60. PubMed ID: 8757633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
